APA

Huang S., Lin C., Lin H., Yao M., Tang J., Wu S., Chen Y., Lu H., Hou H., Chen C., Chou W., Tsay W., Chou S. & Tien H. (20140912). Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. : Annals of hematology.

Chicago

Huang Shang-Yi, Lin Chung-Wu, Lin Hsiu-Hsia, Yao Ming, Tang Jih-Luh, Wu Shang-Ju, Chen Yao-Chang, Lu Hsiao-Yun, Hou Hsin-An, Chen Chien-Yuan, Chou Wen-Chien, Tsay Woei, Chou Sheng-Je and Tien Hwei-Fang. 20140912. Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. : Annals of hematology.

Harvard

Huang S., Lin C., Lin H., Yao M., Tang J., Wu S., Chen Y., Lu H., Hou H., Chen C., Chou W., Tsay W., Chou S. and Tien H. (20140912). Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. : Annals of hematology.

MLA

Huang Shang-Yi, Lin Chung-Wu, Lin Hsiu-Hsia, Yao Ming, Tang Jih-Luh, Wu Shang-Ju, Chen Yao-Chang, Lu Hsiao-Yun, Hou Hsin-An, Chen Chien-Yuan, Chou Wen-Chien, Tsay Woei, Chou Sheng-Je and Tien Hwei-Fang. Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. : Annals of hematology. 20140912.